Optiver Holding B.V. Collegium Pharmaceutical, Inc Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Optiver Holding B.V. holds 130 shares of COLL stock, worth $5,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130Holding current value
$5,829% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
245Shares Held
36.1MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$260 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$142 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$118 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$99.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.6MShares$71.7 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.53B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...